NextCure Inc reports results for the quarter ended in March - Earnings Summary

NextCure

05/05/2023 17:21

* NextCure Inc  NXTC.OQ  reported a quarterly adjusted loss
of 58
cents​​ per share for the quarter ended in March. The mean
expectation of three analysts for the quarter was for a loss
of 62 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * NextCure Inc's reported EPS for the quarter was a loss
of 58
cents​.
    * The mean earnings estimate of analysts had risen by
about 5.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * NextCure Inc shares had risen by 7.4% this quarter and
gained 12.8% so far this year.
    * The company reported a quarterly loss of $16.1 million.
    * Wall Street's median 12-month price target for NextCure
Inc is
$6.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
5 at 04:21 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.62          -0.58          Beat
 Dec. 31 2022      -0.66          -0.62          Beat
 Sep. 30 2022      -0.63          -0.68          Missed
 Jun. 30 2022      -0.72          -0.65          Beat